Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Day One Biopharmaceuticals Inc’s current trading price is -17.62% away from its 52-week high, while its distance from the 52-week low is 36.56%. The stock’s price range over this period has fluctuated between $10.90 and $18.07. The company, operating within the financial sector, had a trading volume of approximately 1.58 million for the day, which was noticeably higher than the average daily share volume of 0.96 million over the last 3 months.
In terms of market performance, Day One Biopharmaceuticals Inc had a fairly even. The highest value for the stock in the past year was $18.07 on 05/01/24, and the lowest value was recorded at $10.90 on 11/13/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Day One Biopharmaceuticals Inc (DAWN) has experienced a quarterly rise of 6.94% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.31B and boasts a workforce of 155 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 14.14, with a change in price of +2.53. Similarly, Day One Biopharmaceuticals Inc recorded 983,752 in trading volume during the last 100 days, posting a change of +20.30%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for DAWN stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
DAWN Stock Stochastic Average
Today’s raw stochastic average for Day One Biopharmaceuticals Inc over the last 50 days is 61.55%.This indicates a increase from the raw stochastic average of the past 20 days, which was 57.94%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 50.68% and 49.62%, respectively.
DAWN Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price increase of 1.95%. However, over the past six months, we’ve seen a stronger performance of -15.28%. The price of DAWN fallen by 9.29% over the last 30 days. And in the last five days, it has surged by 2.87%.
